What are the essential clinical presentation, diagnostic work‑up, and initial management steps for subarachnoid hemorrhage that a medical student should know?

Subarachnoid Hemorrhage: Essential Knowledge for Medical Students

Clinical Presentation

Recognize SAH as a medical emergency with the classic "worst headache of my life" presentation—but understand that this classic presentation occurs in only 74-80% of patients who can give a history. 1

Key Clinical Features to Identify:

• Thunderclap headache: Sudden onset, reaching maximal intensity immediately (not gradually building) 1, 2
• Associated symptoms (present variably):
  • Nausea/vomiting (77%) 1
  • Loss of consciousness (53%) 1
  • Nuchal rigidity/stiff neck (35%) 1
  • Photophobia 1
  • Focal neurological deficits including cranial nerve palsies 1
  • Seizures (up to 20%, most commonly in first 24 hours) 1

Critical Pitfall to Avoid:

Sentinel (warning) headache occurs in 10-43% of patients 2-8 weeks before major rupture—missing this diagnosis increases rebleeding risk 10-fold and results in nearly 4-fold higher likelihood of death or disability. 1 The sentinel headache is typically milder and may last several days, often without meningismus. 1

Misdiagnosis occurs in 12% of cases, with the most common error being failure to obtain a noncontrast head CT. 1

Diagnostic Work-Up

Imaging Algorithm:

1. Noncontrast Head CT (First-Line, Mandatory) 1

• Sensitivity in first 3 days: close to 100% 1
• Sensitivity at 24 hours: 93% 1
• Sensitivity at 5-7 days: drops sharply to 57-85% 1
• If CT is negative but clinical suspicion remains high, proceed immediately to lumbar puncture 1

2. Lumbar Puncture (When CT is Negative or Performed >6 Hours After Onset) 1

• Look for xanthochromia and elevated red blood cell count 1
• Detection of bilirubin in CSF is key 1
• Proper timing, specimen handling, and interpretation are critical 1

3. Vascular Imaging to Identify Aneurysm Source 1

• Digital subtraction angiography (DSA) with 3D rotational angiography is the gold standard (sensitivity and specificity both >98%) 1
• DSA identifies vascular abnormalities in up to 13% of patients with negative CTA 1
• 3D rotational angiography detects aneurysms in 25% of previously negative 2D angiograms 1
• CTA is acceptable for initial evaluation but unreliable for aneurysms <3mm 1

Initial Management Priorities

Immediate Actions (Pre-Aneurysm Obliteration):

1. Blood Pressure Control 1

• Use titratable agents to balance rebleeding risk against maintaining cerebral perfusion pressure 1
• Target systolic BP <160 mmHg is reasonable 1
• Critical because rebleeding risk is 3-4% in first 24 hours (possibly higher), with highest risk in first 2-12 hours 1

2. Nimodipine Administration (Class I, Level A) 1

• Oral nimodipine should be administered to ALL patients with aSAH 1
• Improves neurological outcomes (not by preventing vasospasm, but through other neuroprotective mechanisms) 1
• This is the ONLY proven therapeutic to improve SAH outcome 3

3. Clinical Severity Grading 1

• Rapidly determine severity using Hunt and Hess or World Federation of Neurological Surgeons (WFNS) scale 1
• Initial clinical severity is the most useful indicator of outcome 1

4. Urgent Aneurysm Obliteration 1

• Surgical clipping or endovascular coiling should be performed as early as feasible (ideally <24 hours from ictus) to reduce rebleeding 1
• For aneurysms amenable to both techniques, endovascular coiling should be considered first 1
• Complete obliteration is the goal whenever possible 1

5. Transfer to High-Volume Center 1

• Low-volume hospitals (<10 aSAH cases/year) should transfer patients to high-volume centers (>35 cases/year) with experienced cerebrovascular surgeons, endovascular specialists, and neuro-ICU services 1

Management of Complications:

Acute Hydrocephalus 1

• Manage with cerebrospinal fluid diversion (external ventricular drain or lumbar drainage) 1

Delayed Cerebral Ischemia (DCI) 1

• Maintain euvolemia and normal circulating blood volume for prevention 1
• Induce hypertension for symptomatic DCI unless contraindicated by baseline elevated BP or cardiac status 1
• Consider cerebral angioplasty and/or intra-arterial vasodilators for patients not responding rapidly to hypertensive therapy 1

Key Prognostic Information:

• 12% of patients die before receiving medical attention 1
• Overall mortality approximately 50% 4, 2
• Rebleeding risk: 3-4% in first 24 hours, then 1-2% per day for first month, then 3% per year long-term 1
• Aneurysmal SAH accounts for 70% of all nontraumatic SAH 1